|
WDR7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.70800004642524E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.0720000139014E-09 |
| Normal-vs-Stage2 |
2.157800E-04 |
| Normal-vs-Stage3 |
5.23470000013404E-07 |
| Normal-vs-Stage4 |
1.07510000002531E-06 |
| Stage1-vs-Stage2 |
4.644200E-01 |
| Stage1-vs-Stage3 |
7.032200E-01 |
| Stage1-vs-Stage4 |
1.752560E-01 |
| Stage2-vs-Stage3 |
2.533600E-01 |
| Stage2-vs-Stage4 |
4.200100E-02 |
| Stage3-vs-Stage4 |
2.170400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.85770004618769E-10 |
| Normal-vs-AfricanAmerican |
5.86659999999295E-05 |
| Normal-vs-Asian |
7.79659999999849E-05 |
| Caucasian-vs-AfricanAmerican |
3.207200E-01 |
| Caucasian-vs-Asian |
4.418800E-01 |
| AfricanAmerican-vs-Asian |
3.618200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.52959978017009E-10 |
| Normal-vs-Female |
1.159490E-03 |
| Male-vs-Female |
6.060600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.560900E-04 |
| Normal-vs-Extreme_Weight |
2.52579956949717E-10 |
| Normal-vs-Obese |
2.26910000000746E-06 |
| Normal-vs-Extreme_Obese |
6.244100E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.923430E-01 |
| Normal_Weight-vs-Obese |
8.700200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.703600E-01 |
| Extreme_Weight-vs-Obese |
7.800000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.542800E-01 |
| Obese-vs-Extreme_Obese |
7.616600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.59620000000405E-05 |
| Normal-vs-Age(41-60Yrs) |
4.7090999999444E-07 |
| Normal-vs-Age(61-80Yrs) |
2.42230013824951E-10 |
| Normal-vs-Age(81-100Yrs) |
3.6789000000037E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.436000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.774400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.149000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.599800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.238800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.971800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.55669946219928E-11 |
| Normal-VS-Type2 PRCC |
7.87230000000028E-05 |
| Normal-VS-KIRP CIMP |
9.9598000000034E-05 |
| Normal-VS-Unclassified PRCC |
5.421700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.748100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.704000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.021900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.404400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.927600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.446000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.38169999780646E-08 |
| Normal-vs-N1 |
3.58070000316957E-08 |
| Normal-vs-N2 |
5.462800E-03 |
| N0-vs-N1 |
4.467000E-01 |
| N0-vs-N2 |
8.776000E-01 |
| N1-vs-N2 |
8.446200E-01 |
|
|
